APPLICATION FOR SUBSIDY BY SPECIAL AUTHORITY

Size: px
Start display at page:

Download "APPLICATION FOR SUBSIDY BY SPECIAL AUTHORITY"

Transcription

1 APPLICANT (stamp sticker acceptable) Page 1 Fm SA1603 Insulin Pumps INITIAL APPLICATION - permanent neonatal diabetes Applications only from a relevant specialist nurse practitioner. Approvals valid f 3 months. Patient has permanent neonatal diabetes A MDI regimen trial is inappropriate Has been evaluated by the multidisciplinary team f their suitability f insulin pump therapy Patient/Parent/Guardian has undertaken carbohydrate counting education (either a carbohydrate counting course direct education from an appropriate health professional) Applicant is part of a multidisciplinary team experienced in the management of type 1 diabetes care Applicant is a nurse practitioner wking within their vocational scope RENEWAL - permanent neonatal diabetes Applications only from a relevant specialist nurse practitioner. Approvals valid f 3 months. Patient is continuing to derive benefit accding to the treatment plan agreed at induction Patient remains fully compliant transition to MDI is considered inappropriate by the treating physician It has been at least 4 years since the last insulin pump received by the patient, in the case of patients qualifying under previous pump therapy f the initial application; the pump is due f replacement Applicant is a nurse practitioner wking within their vocational scope See also: INITIAL APPLICATION - severe unexplained hypoglycaemia p2, RENEWAL - severe unexplained hypoglycaemia p3, INITIAL APPLICATION - HbA1c p4, RENEWAL - HbA1c p5, INITIAL APPLICATION - Previous use befe 1 September 2012 p6 RENEWAL - Previous use befe 1 September 2012 p7 I confirm the above details are crect that in signing this fm I underst I may be audited.

2 APPLICANT (stamp sticker acceptable) Page 2 Fm SA1603 INITIAL APPLICATION - severe unexplained hypoglycaemia Applications only from a relevant specialist nurse practitioner. Approvals valid f 3 months. Patient has type 1 diabetes has undergone a pancreatectomy has cystic fibrosis-related diabetes Has undertaken carbohydrate counting education (either a carbohydrate counting course direct education from an appropriate health professional) Applicant is part of a multidisciplinary team experienced in the management of type 1 diabetes care Has adhered to an intensive MDI regimen using analogue insulins f at least six months Has had four severe unexplained hypoglycaemic episodes over a six month period (severe as defined as requiring the assistance of another person) Has an average HbA1c between the following range: equal to greater than 53 mmol/mol equal to less than 90 mmol/mol Has been evaluated by the multidisciplinary team f their suitability f insulin pump therapy Applicant is a nurse practitioner wking within their vocational scope See also: RENEWAL - severe unexplained hypoglycaemia p3, INITIAL APPLICATION - HbA1c p4, RENEWAL - HbA1c p5, INITIAL APPLICATION - Previous use befe 1 September 2012 p6 RENEWAL - Previous use befe 1 September 2012 p7 I confirm the above details are crect that in signing this fm I underst I may be audited.

3 APPLICANT (stamp sticker acceptable) Page 3 Fm SA1603 RENEWAL - severe unexplained hypoglycaemia Applications only from a relevant specialist nurse practitioner. Approvals valid f 3 months. Patient is continuing to derive benefit accding to the treatment plan agreed at induction of at least a 50% reduction from baseline in hypoglycaemic events HbA1c has not increased by me than 5 mmol/mol from baseline The pump is due f replacement Applicant is a nurse practitioner wking within their vocational scope See also: INITIAL APPLICATION - HbA1c p4, RENEWAL - HbA1c p5, INITIAL APPLICATION - Previous use befe 1 September 2012 p6 RENEWAL - Previous use befe 1 September 2012 p7 I confirm the above details are crect that in signing this fm I underst I may be audited.

4 APPLICANT (stamp sticker acceptable) Page 4 Fm SA1603 INITIAL APPLICATION - HbA1c Applications only from a relevant specialist nurse practitioner. Approvals valid f 3 months. Patient has type 1 diabetes has undergone a pancreatectomy has cystic fibrosis-related diabetes Has undertaken carbohydrate counting education (either a carbohydrate counting course direct education from an appropriate health professional) Applicant is part of a multidisciplinary team experienced in the management of type 1 diabetes care Has adhered to an intensive MDI regimen using analogue insulins f at least six months Has unpredictable significant variability in blood glucose including significant hypoglycaemia affecting the ability to reduce HbA1 In the opinion of the treating clinician, HbA1c could be reduced by at least 10 mmol/mol using insulin pump treatment Has typical HbA1c results between the following range: equal to greater than 65 mmol/mol equal to less than 90 mmol/mol Has been evaluated by the multidisciplinary team f their suitability f insulin pump therapy Applicant is a nurse practitioner wking within their vocational scope See also: RENEWAL - HbA1c p5, INITIAL APPLICATION - Previous use befe 1 September 2012 p6 RENEWAL - Previous use befe 1 September 2012 p7 I confirm the above details are crect that in signing this fm I underst I may be audited.

5 APPLICANT (stamp sticker acceptable) Page 5 Fm SA1603 RENEWAL - HbA1c Applications only from a relevant specialist nurse practitioner. Approvals valid f 3 months. Patient is continuing to derive benefit accding to the treatment plan agreed at induction of achieving maintaining a reduction in HbA1c from baseline of 10 mmol/mol The number of severe unexplained recurrent hypoglycaemic episodes has not increased from baseline The pump is due f replacement Applicant is a nurse practitioner wking within their vocational scope See also: INITIAL APPLICATION - Previous use befe 1 September 2012 p6 RENEWAL - Previous use befe 1 September 2012 p7 I confirm the above details are crect that in signing this fm I underst I may be audited.

6 APPLICANT (stamp sticker acceptable) Page 6 Fm SA1603 INITIAL APPLICATION - Previous use befe 1 September 2012 Applications only from a relevant specialist nurse practitioner. Approvals valid f 3 months. Patient has type 1 diabetes has undergone a pancreatectomy has cystic fibrosis-related diabetes Was already on pump treatment pri to 1 September 2012 had been evaluated by the multidisciplinary team f their suitability f insulin pump therapy at the time of initiating that pump treatment continues to benefit from pump treatment The patient has adhered to an intensive MDI regimen using analogue insulins f at least six months pri to initiating pump therapy The patient is continuing to derive benefit from pump therapy The patient had achieved is maintaining a HbA1c of equal to less than 80 mmol/mol on pump therapy The patient has had no increase in severe unexplained hypoglycaemic episodes from baseline The patient s HbA1c has not deteriated me than 5 mmol/mol from baseline The pump is due f replacement Applicant is a nurse practitioner wking within their vocational scope See also: RENEWAL - Previous use befe 1 September 2012 p7 I confirm the above details are crect that in signing this fm I underst I may be audited.

7 APPLICANT (stamp sticker acceptable) Page 7 Fm SA1603 RENEWAL - Previous use befe 1 September 2012 Applications only from a relevant specialist nurse practitioner. Approvals valid f 3 months. The patient is continuing to derive benefit accding to the treatment plan has maintained a HbA1c of equal to less than 80 mmol/mol The patient s HbA1c has not deteriated me than 5 mmol/mol fromthe time of commencing pump treatment The patient has not had an increase in severe unexplained hypoglycaemic episodes from baseline The pump is due f replacement Applicant is a nurse practitioner wking within their vocational scope I confirm the above details are crect that in signing this fm I underst I may be audited.

SPECIAL AUTHORITY FORMS November 2018

SPECIAL AUTHORITY FORMS November 2018 SPECIAL AUTHORITY FORMS Contents Panel Approvals... 4 Alimentary Tract Metabolism... 6 Blood Blood Fming Organs... 40 Cardiovascular System... 54 Dermatologicals... 67 Genito-Urinary System... 73 Hmone

More information

Audit support for continuous subcutaneous insulin infusion for the treatment of diabetes mellitus (review of technology appraisal guidance 57)

Audit support for continuous subcutaneous insulin infusion for the treatment of diabetes mellitus (review of technology appraisal guidance 57) Audit support for continuous subcutaneous insulin (review of technology appraisal guidance 57) Issue date: 2008 Audit support Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus

More information

Policy for the Provision of Insulin Pumps for Patients with Diabetes Mellitus

Policy for the Provision of Insulin Pumps for Patients with Diabetes Mellitus Policy for the Provision of Insulin Pumps for Patients with Diabetes Mellitus Version No. Changes Made Version of July 2018 V0.5 Changes made to the policy following patient engagement including: - the

More information

Policy for the Provision of Continuous Glucose Monitoring and Flash Glucose Monitoring to patients with Diabetes Mellitus

Policy for the Provision of Continuous Glucose Monitoring and Flash Glucose Monitoring to patients with Diabetes Mellitus Policy for the Provision of Continuous Glucose Monitoring and Flash Glucose Monitoring to patients with Diabetes Mellitus Version No. Changes Made Version of 05.10.2018 V1 Policy ratified by Healthier

More information

Placename CCG. Policies for the Commissioning of Healthcare

Placename CCG. Policies for the Commissioning of Healthcare Placename CCG Policies for the Commissioning of Healthcare Policy for the Provision of Continuous Glucose Monitoring and Flash Glucose Monitoring to patients with Diabetes Mellitus. This document is part

More information

APPLICATION FOR SUBSIDY BY SPECIAL AUTHORITY

APPLICATION FOR SUBSIDY BY SPECIAL AUTHORITY Page 1 Somatropin INITIAL APPLICATION - growth hmone deficiency in children Growth hmone deficiency causing symptomatic hypoglycaemia, with other significant growth hmone deficient sequelae (e.g. cardiomyopathy,

More information

Placename CCG. Policies for the Commissioning of Healthcare

Placename CCG. Policies for the Commissioning of Healthcare Placename CCG Policies for the Commissioning of Healthcare Policy for the funding of insulin pumps and continuous glucose monitoring devices for patients with diabetes 1 Introduction 1.1 This document

More information

NHS BLOOD AND TRANSPLANT ORGAN DONATION AND TRANSPLANTATION DIRECTORATE PANCREAS ADVISORY GROUP AUDIT OF STANDARD CRITERIA FOR LISTING SUMMARY

NHS BLOOD AND TRANSPLANT ORGAN DONATION AND TRANSPLANTATION DIRECTORATE PANCREAS ADVISORY GROUP AUDIT OF STANDARD CRITERIA FOR LISTING SUMMARY INTRODUCTION NHS BLOOD AND TRANSPLANT ORGAN DONATION AND TRANSPLANTATION DIRECTORATE PANCREAS ADVISORY GROUP AUDIT OF STANDARD CRITERIA FOR LISTING SUMMARY 1 Selection criteria for patients onto the national

More information

APPLICATION FOR SUBSIDY BY SPECIAL AUTHORITY

APPLICATION FOR SUBSIDY BY SPECIAL AUTHORITY The patient has increased nutritional requirements APPLICANT (stamp sticker acceptable) Page 1 Fm SA1554 Stard Supplements (Ensure; Ftisip; Isosource; Jevity; Nutrison; Osmolite; Sustagen) INITIAL APPLICATION

More information

Monitoring in Type 2 Diabetes. Learning Outcomes. Type 2 Diabetes. Senga Hunter Community Diabetes Specialist Nurse

Monitoring in Type 2 Diabetes. Learning Outcomes. Type 2 Diabetes. Senga Hunter Community Diabetes Specialist Nurse Monitoring in Type 2 Diabetes Senga Hunter Community Diabetes Specialist Nurse Learning Outcomes Understand why blood monitoring is necessary Understand the blood tests for monitoring diabetes Understand

More information

APPLICATION FOR SUBSIDY BY SPECIAL AUTHORITY

APPLICATION FOR SUBSIDY BY SPECIAL AUTHORITY Page 1 Rituximab INITIAL APPLICATION - Post-transplant The patient has B-cell post-transplant lymphoproliferative disder* To be used f a maximum of 8 treatment cycles Indications marked with * are Unapproved

More information

Diabetes Subcommittee of PTAC meeting held 3 March (minutes for web publishing)

Diabetes Subcommittee of PTAC meeting held 3 March (minutes for web publishing) Diabetes Subcommittee of PTAC meeting held 3 March 2011 (minutes for web publishing) Diabetes Subcommittee minutes are published in accordance with the Terms of Reference for the Pharmacology and Therapeutics

More information

SFHDiabPT03 Provide dietary education for an individual with Type 1 diabetes who is contemplating insulin pump therapy

SFHDiabPT03 Provide dietary education for an individual with Type 1 diabetes who is contemplating insulin pump therapy Provide dietary education for an individual with Type 1 diabetes who is contemplating insulin pump therapy Overview This standard concerns the activities of helping an individual with diabetes understand

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE)

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE) NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE) Review of TA151 Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus This guidance was issued in

More information

Policy for Continuous Glucose Monitoring for Type 1 Diabetic Paediatric Patients (<18 years of age)

Policy for Continuous Glucose Monitoring for Type 1 Diabetic Paediatric Patients (<18 years of age) Policy for Continuous Glucose Monitoring for Type 1 Diabetic Paediatric Patients (

More information

Standard Operating Procedure Completion of DAFNE data collection: Core baseline form F04.007

Standard Operating Procedure Completion of DAFNE data collection: Core baseline form F04.007 Standard Operating Procedure Completion of DAFNE data collection: Core baseline form F04.007 DAFNE P01.013 version 10, February 2016 1 of 10 CONTENTS Introduction... 3 Patient DAFNE number... 3 Type of

More information

Personal statement on Continuous Subcutaneous Insulin Infusion Professor John Pickup

Personal statement on Continuous Subcutaneous Insulin Infusion Professor John Pickup 1 Personal statement on Continuous Subcutaneous Insulin Infusion Professor John Pickup King s College London School of Medicine, Guy s Hospital, London SE1 9RT Experience of the technology I am the lead

More information

Type 1 Diabetes: diagnosis and management. Stakeholder workshop

Type 1 Diabetes: diagnosis and management. Stakeholder workshop Type 1 Diabetes: diagnosis and management Stakeholder workshop 28 th May 2012 Royal College of Paediatrics & Child Health: 5-11 Theobalds Road, London WC1X 8SH Summary notes The stakeholder scoping workshop

More information

THE SHEFFIELD AREA PRESCRIBING GROUP. Position Statement for Prescribing of Freestyle Libre In Type 1 Diabetes. Date: March 2018.

THE SHEFFIELD AREA PRESCRIBING GROUP. Position Statement for Prescribing of Freestyle Libre In Type 1 Diabetes. Date: March 2018. THE SHEFFIELD AREA PRESCRIBING GROUP Position Statement for Prescribing of Freestyle Libre In Type 1 Diabetes Date: March 2018 Overview Freestyle Libre is a flash glucose sensor device that measures *interstitial

More information

Insulin pumps. Norman Waugh Warwick Medical School.

Insulin pumps. Norman Waugh Warwick Medical School. Insulin pumps Norman Waugh Warwick Medical School norman.waugh@warwick.ac.uk Insulin pumps Small device to support continuous subcutaneous insulin infusion Alternative to multiple daily injections (MDI)

More information

Guideline for antihyperglycaemic therapy in adults with type 2 diabetes

Guideline for antihyperglycaemic therapy in adults with type 2 diabetes Guideline for antihyperglycaemic therapy in adults with type 2 diabetes Version Control Version Number Date Amendments made 1 January 2018 1.1 February 2018 Amended to reflect updated SPC advice for sitagliptin

More information

Commissioning Statement

Commissioning Statement Commissioning Statement Treatment/ device For the treatment of Commissioning position Flash Glucose Monitoring Systems (including Freestyle Libre ) Monitoring glucose levels in adults and children over

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Health Technology Appraisal

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Health Technology Appraisal NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Health Technology Appraisal Continuous subcutaneous insulin infusion for the treatment of diabetes (review) Final scope Appraisal objective To review

More information

APPLICATION FOR SPECIAL AUTHORITY. Subsidy for Infliximab

APPLICATION FOR SPECIAL AUTHORITY. Subsidy for Infliximab APPLICATION FOR SPECIAL AUTHORITY Fm SA1778 Subsidy f Infliximab Application Categy Page Graft vs host disease - Initial application... 2 Pulmonary sarcoidosis - Initial application... 2 Previous use -

More information

APPLICATION FOR SUBSIDY BY SPECIAL AUTHORITY

APPLICATION FOR SUBSIDY BY SPECIAL AUTHORITY APPLICANT (stamp sticker acceptable) Page 1 Fm SA1620 Etanercept INITIAL APPLICATION - juvenile idiopathic arthritis Applications only from a named specialist rheumatologist. Approvals valid f 6 months.

More information

APPLICATION FOR SUBSIDY BY SPECIAL AUTHORITY

APPLICATION FOR SUBSIDY BY SPECIAL AUTHORITY APPLICANT (stamp sticker acceptable) Page 1 Fm SA1621 Adalimumab INITIAL APPLICATION - rheumatoid arthritis Applications only from a rheumatologist. Approvals valid f 6 months. The patient has had an initial

More information

Administration of Injectable Medication by Healthcare Assistants (Band 3) Standard Operating Procedure

Administration of Injectable Medication by Healthcare Assistants (Band 3) Standard Operating Procedure Administration of Injectable Medication by Healthcare Assistants (Band 3) Standard Operating Procedure DOCUMENT CONTROL: Version: 1 Ratified by: Quality Assurance Sub Committee Date ratified: 4 September

More information

APPLICATION FOR SPECIAL AUTHORITY. Subsidy for Tocilizumab

APPLICATION FOR SPECIAL AUTHORITY. Subsidy for Tocilizumab APPLICATION FOR SPECIAL AUTHORITY Fm SA1781 Subsidy f Tocilizumab Application Categy Page Cytokine release syndrome - Initial application... 2 Previous use - Initial application... 2 Rheumatoid Arthritis

More information

Guidance on the Self-Monitoring of Blood Glucose in Adults with Diabetes

Guidance on the Self-Monitoring of Blood Glucose in Adults with Diabetes Introduction Guidance on the Self-Monitoring of Blood Glucose in Adults with Diabetes This guideline is designed to offer guidance for primary and secondary care on the use of selfmonitoring of blood glucose

More information

National Diabetes Inpatient Audit (NaDIA) 2016

National Diabetes Inpatient Audit (NaDIA) 2016 National Diabetes Inpatient Audit (NaDIA) 2016 DIABETES A summary report for people with diabetes and anyone interested in the quality of care for people with diabetes when they stay in hospital. Based

More information

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) JAPC Briefing FreeStyle Libre

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) JAPC Briefing FreeStyle Libre DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) JAPC Briefing FreeStyle Libre JAPC has classified Freestyle Libre as BROWN after diabetes consultant/specialist initiation within a Derbyshire diabetes

More information

Cystic Fibrosis Panel Applications (Dornase Alfa) Contents

Cystic Fibrosis Panel Applications (Dornase Alfa) Contents Cystic Fibrosis Panel Applications (Dornase Alfa) Contents Page 2-4: Entry and Stopping Criteria for Treatment with Dornase Alfa Page 5-9: Application and consent forms for a one month trail and long term

More information

NHS GG&C Introduction of Freestyle Libre flash glucose monitoring system

NHS GG&C Introduction of Freestyle Libre flash glucose monitoring system NHS GG&C Introduction of Freestyle Libre flash glucose monitoring system The Freestyle Libre flash glucose monitoring system is a sensor based, factory-calibrated system that measures interstitial fluid

More information

SFHDiabIPT01. Assess the suitability of insulin pump therapy for an individual with Type 1 diabetes. Overview

SFHDiabIPT01. Assess the suitability of insulin pump therapy for an individual with Type 1 diabetes. Overview Assess the suitability of insulin pump therapy for an individual with Type Overview This standard covers the activities associated with assessing the suitability of insulin pump therapy for individuals

More information

9 Diabetes care. Back to contents

9 Diabetes care. Back to contents Back to contents Diabetes is a major risk factor for the development of peripheral vascular disease and 349/628 (55.6%) of the patients in this study had diabetes. Hospital inpatients with diabetes are

More information

EAST OF ENGLAND CHILDREN AND YOUNG PEOPLE S DIABETES NETWORK. Optimising Glycaemic Control for Children and Young People with Diabetes

EAST OF ENGLAND CHILDREN AND YOUNG PEOPLE S DIABETES NETWORK. Optimising Glycaemic Control for Children and Young People with Diabetes EAST OF ENGLAND CHILDREN AND YOUNG PEOPLE S DIABETES NETWORK Optimising Glycaemic Control for Children and Young People with Diabetes Local diabetes teams need to take on the responsibility of ensuring

More information

Commissioning for Outcomes in Diabetes. Joanne Taylor Primary Care Commissioning Manager

Commissioning for Outcomes in Diabetes. Joanne Taylor Primary Care Commissioning Manager Commissioning for Outcomes in Diabetes Joanne Taylor Primary Care Commissioning Manager Current Diabetes Model in Dudley History and Current Diabetes Pathway Primary Care 46 2 no LIS practices Annual review

More information

Integrated Community Diabetes Services (ICDS) GP Referral Guide Version 3 - October 2014

Integrated Community Diabetes Services (ICDS) GP Referral Guide Version 3 - October 2014 Integrated Community Diabetes Services (ICDS) GP Referral Guide Version 3 - October 2014 Introduction The Integrated Community Diabetes Service (ICDS) will deliver high quality care to individuals who

More information

Draft Implementation Plan for Consultation Adult Type 1 Diabetes Guidelines

Draft Implementation Plan for Consultation Adult Type 1 Diabetes Guidelines Draft Implementation Plan for Consultation Adult Type 1 Diabetes Guidelines 1 Adult Type 1 Diabetes Guidelines - Implementation Plan 1. Introduction The following section is a national implementation plan,

More information

DIABETES BLOOD GLUCOSE MONITORING AT HOME (ADULTS)

DIABETES BLOOD GLUCOSE MONITORING AT HOME (ADULTS) DIABETES BLOOD GLUCOSE MONITORING AT HOME (ADULTS) Type 2 Diabetes Clinical Guideline Self-monitoring of blood glucose (SMBG) should be considered but not routinely offered for adults with type 2 diabetes

More information

Diabetes group education classes

Diabetes group education classes These group education classes are available for patients who: have newly diagnosed type 2 diabetes have type 2 diabetes and are on insulin, or starting on insulin use an insulin pump or are starting to

More information

Standard Operating Procedure 11. Completion of DAFNE Data Collection: Full Post Course Form F04.010, Version 8

Standard Operating Procedure 11. Completion of DAFNE Data Collection: Full Post Course Form F04.010, Version 8 Standard Operating Procedure 11 Completion of DAFNE Data Collection: Full Post Course Form F04.010, Version 8 Date Version Issue Review Contact Approved Date Date Person October 2013 9 October 2013 March

More information

New NICE guidance: Changes in practice for multidisciplinary teams. Part 1: Type 1 diabetes in children and young people

New NICE guidance: Changes in practice for multidisciplinary teams. Part 1: Type 1 diabetes in children and young people Article New NICE guidance: Changes in practice for multidisciplinary teams. Part 1: Type 1 diabetes in children and young people Helen Thornton This is the first of two articles on the 2015 NICE NG18 guideline,

More information

NHS Leeds CCG. Policy for the Funding of Flash Glucose Monitoring (FlashGM) in Paediatrics and Adults

NHS Leeds CCG. Policy for the Funding of Flash Glucose Monitoring (FlashGM) in Paediatrics and Adults NHS Leeds CCG Policy for the Funding of Flash Glucose Monitoring (FlashGM) in Paediatrics and Adults Produced by: Jo Alldred, Medicines Effectiveness Lead, NHS Leeds CCG Dr Bryan Power, Long Term Conditions

More information

The most recent estimates suggest that. A study of inpatient diabetes care on medical wards. Saqib Javed, Yaser Javed, Kate Barnabas, Kalpana Kaushal

The most recent estimates suggest that. A study of inpatient diabetes care on medical wards. Saqib Javed, Yaser Javed, Kate Barnabas, Kalpana Kaushal A study of inpatient diabetes care on medical wards Saqib Javed, Yaser Javed, Kate Barnabas, Kalpana Kaushal Article points 1. It is well established that poor glycaemic control is associated with increased

More information

Commissioning Statement. Flash Glucose Monitoring system (FreeStyle Libre ) March 2018

Commissioning Statement. Flash Glucose Monitoring system (FreeStyle Libre ) March 2018 Technology Commissioning Statement Flash Glucose Monitoring system (FreeStyle Libre ) March 2018 FreeStyle Libre (Abbott) Flash Glucose Monitoring System for use in adults, young people and children. Recommendation

More information

Self-assessment checklist

Self-assessment checklist Self-assessment checklist 1 1 All hospitals should have a fully staffed diabetes inpatient team, made up of the following 1 : consultant. Sufficient diabetes inpatient specialist nurses to run a daily

More information

Commissioning Policy Individual Funding Request

Commissioning Policy Individual Funding Request Commissioning Policy Individual Funding Request Continuous Glucose Monitors Prior Approval Policy Date Adopted: 13 October 2017 Version: 1718.2 Document Control Title of document Continuous Glucose Monitors

More information

Description of the technology

Description of the technology Advice Note 2017/ 001 What is the clinical effectiveness, safety and budget impact of the Freestyle Libre System compared with current glucose monitoring methods for people aged 4 years and over with diabetes

More information

Referral to Adult Diabetes Specialist Services

Referral to Adult Diabetes Specialist Services Referral to Adult Diabetes Services Aim(s) and objective(s) To ensure that those people with Diabetes Mellitus (DM) who live within Lanarkshire are appropriately referred to the Diabetes Service (Consultant,

More information

Initiation of insulin adjustment for carbohydrate at onset of diabetes in children using a home-based education programme with a bolus calculator

Initiation of insulin adjustment for carbohydrate at onset of diabetes in children using a home-based education programme with a bolus calculator Initiation of insulin adjustment for carbohydrate at onset of diabetes in children using a home-based education programme with a bolus calculator H Thom 1 BSc (Hons), Paediatric Diabetes Dietitian S Greene

More information

Islet and Pancreas Transplantation

Islet and Pancreas Transplantation Islet and Pancreas Transplantation Julie Wardle Specialist Nurse Coordinator Indication for Transplant Treatment option for a select groups of patients with type 1 diabetes Aged 18 years or over Recurrent

More information

University College Hospital. Blood glucose and HbA 1 c targets

University College Hospital. Blood glucose and HbA 1 c targets University College Hospital Blood glucose and HbA 1 c targets Children & Young People s Diabetes Service The diabetes team at UCLH aims to help every child and young person with Type 1 Diabetes to safely

More information

SHARED CARE GUIDELINE ON THE USE OF FIASP FOR THE MANAGEMENT OF TYPE 1 DIABETES IN ADULTS

SHARED CARE GUIDELINE ON THE USE OF FIASP FOR THE MANAGEMENT OF TYPE 1 DIABETES IN ADULTS SHARED CARE GUIDELINE ON THE USE OF FIASP FOR THE MANAGEMENT OF TYPE 1 DIABETES IN ADULTS INDICATION Fiasp is indicated for the treatment of diabetes mellitus in adults. Special Note: DMAG has approved

More information

medicines_management/correspondence/pathway-for-the-managed- Access-of-FreeStyle-Libre.

medicines_management/correspondence/pathway-for-the-managed- Access-of-FreeStyle-Libre. Pathway for the Managed Access of FreeStyle Libre (Flash Glucose monitoring) for Adults and Children in the care of Trust Specialist Diabetes Clinics in Northern Ireland www.hscboard.hscni.net/download/publications/pharmacy_and_

More information

Benefit Criteria for Diabetic Equipment and Supplies Home Health Services Changing July 1, 2011

Benefit Criteria for Diabetic Equipment and Supplies Home Health Services Changing July 1, 2011 Benefit Criteria for Diabetic Equipment and Supplies Home Health Services Changing July 1, 2011 Information posted May 13, 2011 Effective for dates of service on or after July 1, 2011, the benefit criteria

More information

Insulin Pumps and Glucose Monitors in Adults Policy

Insulin Pumps and Glucose Monitors in Adults Policy Insulin Pumps and Glucose Monitors in Adults Policy Version: 2016-19 Ratified by: NHS Leeds West CCG Assurance Committee on; 16 November 2016 NHS Leeds North CCG Governance on Performance and Risk Committee

More information

hypoglycaemia unawareness keystone 18 July 2014

hypoglycaemia unawareness keystone 18 July 2014 hypoglycaemia unawareness keystone 18 July 2014 Hypoglycaemia unawareness: ( Impaired awareness of hypoglycaemia ) Philip Home Newcastle University Philip Home Duality of interest Manufacturers of glucose-lowering

More information

Patients undergoing Bariatric surgery with type 2 diabetes on antidiabetic drugs WITHOUT insulin, when starting liver shrinking diet: Guidance for GPs

Patients undergoing Bariatric surgery with type 2 diabetes on antidiabetic drugs WITHOUT insulin, when starting liver shrinking diet: Guidance for GPs Patients undergoing Bariatric surgery with type 2 diabetes on antidiabetic drugs WITHOUT insulin, when starting liver shrinking diet: Guidance for GPs Subject: Policy Number Ratified By: Patients with

More information

Paolo Di Bartolo U.O di Diabetologia Dip. Malattie Digestive & Metaboliche AULS Prov. di Ravenna. Ipoglicemie e Monitoraggio Glicemico

Paolo Di Bartolo U.O di Diabetologia Dip. Malattie Digestive & Metaboliche AULS Prov. di Ravenna. Ipoglicemie e Monitoraggio Glicemico Paolo Di Bartolo U.O di Diabetologia Dip. Malattie Digestive & Metaboliche AULS Prov. di Ravenna Ipoglicemie e Monitoraggio Glicemico Management of Hypoglycaemia.if hypoglycemia is a problem, the principles

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Diabetes in children and young people: diagnosis and management of type 1 and type 2 diabetes in children and young people

More information

Diabetes and Pregnancy

Diabetes and Pregnancy Diabetes and Pregnancy Dr Warren Gillibrand Deputy Director of Postgraduate Education Department of Nursing & Midwifery Department of AHP and Sports Science w.p.gillibrand@hud.ac.uk Aims of the session

More information

Diabetes is a lifelong, chronic. Survey on the quality of diabetes care in prison settings across the UK. Keith Booles

Diabetes is a lifelong, chronic. Survey on the quality of diabetes care in prison settings across the UK. Keith Booles Survey on the quality of diabetes care in prison settings across the UK Article points 1. The Royal College of Nursing Diabetes Forum conducted an audit of prisons within the UK to determine the level

More information

2012 Edition. Part B: 3 3. DIABETES MELLITUS Effects of diabetes on driving Evidence of crash risk. 3.2.

2012 Edition. Part B: 3 3. DIABETES MELLITUS Effects of diabetes on driving Evidence of crash risk. 3.2. 2012 Edition DIABETES MELLITUS 3. DIABETES MELLITUS Refer also to section 6 Neurological conditions, section 2 Cardiovascular conditions, section 8 Sleep disorders section 10 Vision eye disorders. 3.1

More information

Trust Guideline for the Management of: Insulin Pump Therapy in Children with Type 1 Diabetes

Trust Guideline for the Management of: Insulin Pump Therapy in Children with Type 1 Diabetes A clinical guideline recommended for use In: By: For: Key words: Written by: Supported by: Approved by: Jenny Lind Children s Department Jenny Lind Diabetes Team Children on CSII therapy CSII, Insulin

More information

National Diabetes Insulin Pump Audit, England and Wales

National Diabetes Insulin Pump Audit, England and Wales National Diabetes Insulin Pump Audit, 2016-2017 England and Wales V0.22 7 March 2017 Prepared in collaboration with: The Healthcare Quality Improvement Partnership (HQIP). The National Diabetes Audit (NDA)

More information

Sample CPD Portfolio for a Clinician

Sample CPD Portfolio for a Clinician CPD COMPULSORY CATEGORY ONE CLINICAL PRACTICE / DIABETES EDUCATION / COUNSELLING 23/06/2012 Attended ADEA Branch conference 1 day 8 1 2/11/2011 Attended Health Coaching for Health Professionals training

More information

In keeping with the Scottish Diabetes Group criteria, use should be restricted to those who:

In keeping with the Scottish Diabetes Group criteria, use should be restricted to those who: Advice Statement 009-18 July 2018 Advice Statement What is the clinical and cost effectiveness of Freestyle Libre flash glucose monitoring for patients with diabetes mellitus treated with intensive insulin

More information

DIABETES BLOOD GLUCOSE MONITORING AT HOME (ADULTS)

DIABETES BLOOD GLUCOSE MONITORING AT HOME (ADULTS) Type 2 Diabetes DIABETES BLOOD GLUCOSE MONITORING AT HOME (ADULTS) Clinical Guideline Self-monitoring of blood glucose (SMBG) should be considered but not be routinely offered for adults with type 2 diabetes

More information

Examples of Reflection / Learning Outcomes

Examples of Reflection / Learning Outcomes Examples of Clinician Reflection Now responding to patient s blood glucose record more respectfully and asking patient for permission before giving advice. Helping client to brainstorm their own solutions

More information

DAFNE Audit Auditor Questionnaire

DAFNE Audit Auditor Questionnaire DAFNE Audit Auditor Questionnaire Centre: «Centre» Lead Educator: «Lead_Educator» Date of QA audit visit: «Audit_Date» Auditor: «Auditor» Period covered by audit: From «Period_from» to «Period_to» Auditor

More information

Children s Diabetes Patient Information Leaflet High HbA1c the Surgical Assessment Unit (SAU)

Children s Diabetes Patient Information Leaflet High HbA1c the Surgical Assessment Unit (SAU) Children s Diabetes Patient Information Leaflet High HbA1c the Surgical Assessment Unit (SAU) You have been given this leaflet because you have a high HbA1c. This leaflet tells you: what HbA1c is what

More information

Insulin Pumps and Glucose Monitors in Adults, Children and Young People Policy

Insulin Pumps and Glucose Monitors in Adults, Children and Young People Policy Insulin Pumps and Glucose Monitors in Adults, Children and Young People Policy Version: 2017-20 Ratified by: NHS Leeds West CCG Assurance Committee on; 16 November 2016 NHS Leeds North CCG Governance on

More information

Implementation of Freestyle Libre prescribing guidance across the NHS in London

Implementation of Freestyle Libre prescribing guidance across the NHS in London Implementation of FreeStyle Libre prescribing guidance across the NHS in London Contents Section 1 Background to the document (pages 2-5) Section 2 Implementation guidance pathways 1. Recommended implementation

More information

Paediatric Diabetes Service Operational Policy

Paediatric Diabetes Service Operational Policy Paediatric Diabetes Service Operational Policy Department / Service: Paediatric Diabetes Service Originator: Dr John Scanlon Diane Cluley PDSN Accountable Director: Dr Andrew Short Approved by: Paediatric

More information

Walsall CCG Supported Blood Glucose Meters April 2018

Walsall CCG Supported Blood Glucose Meters April 2018 Meter Name Picture Type Strips Lancets Information Company PRIMARY CARE INITIATION TEE2+ Uncomplicated Type 2 diabetes patient on TEE2 test CareSens Lancets Easy to use. Large clear display Bluetooth functionality

More information

What is the role of insulin pumps in the modern day care of patients with Type 1 diabetes?

What is the role of insulin pumps in the modern day care of patients with Type 1 diabetes? What is the role of insulin pumps in the modern day care of patients with Type 1 diabetes? Dr. Fiona Wotherspoon Consultant in Diabetes and Endocrinology Dorset County Hospital Fiona.Wotherspoon@dchft.nhs.uk

More information

Management of adults with diabetes undergoing surgery and elective procedures: Improving standards

Management of adults with diabetes undergoing surgery and elective procedures: Improving standards Management of adults with diabetes undergoing surgery and elective procedures: Improving standards Revised September 2015 Changes in the second edition of the peri-operative document Preoperative pathway

More information

Summary of Significant Changes. Policy

Summary of Significant Changes. Policy This Policy replaces POL185/3 Copy Number Effective 02/08/2016 Summary of Significant Changes Inclusion of Simultaneous Islet and Kidney transplants Policy This policy has been created by the Pancreas

More information

Type 1 diabetes: diagnosis and management of type 1 diabetes in children, young people and adults

Type 1 diabetes: diagnosis and management of type 1 diabetes in children, young people and adults Type 1 diabetes: diagnosis and management of type 1 diabetes in children, young people and adults Clinical Guideline 15 July 2004 eveloped by the National Collaborating Centre for Women s and Children

More information

Angela Girelli e Giorgio Grassi. Stato dell arte del paziente in SAP Ipoglicemia e variabilità glicemica

Angela Girelli e Giorgio Grassi. Stato dell arte del paziente in SAP Ipoglicemia e variabilità glicemica Angela Girelli e Giorgio Grassi Stato dell arte del paziente in SAP Ipoglicemia e variabilità glicemica Le basi sperimentali Glycemia Ceriello A:Diabetes 2008: 57: 1349 1354 17.50 15.50 Glycemia (mmol/l)

More information

Pre admission & surgery Pre-admission Nurses Association SIG Catherine Prochilo Credentialled Diabetes Nurse Educator Sat 23 March 2013

Pre admission & surgery Pre-admission Nurses Association SIG Catherine Prochilo Credentialled Diabetes Nurse Educator Sat 23 March 2013 Pre admission & surgery Pre-admission Nurses Association SIG Catherine Prochilo Credentialled Diabetes Nurse Educator Sat 23 March 2013 www.diabetesvic.org.au Plan/ overview Issue/ presenting problems

More information

Insulin Pump and Supplies Policy and Administration Manual

Insulin Pump and Supplies Policy and Administration Manual Ministry of Health & Long-Term Care Insulin Pump and Supplies Policy and Administration Manual Assistive Devices Program Ministry of Health & Long-Term Care www.health.gov.on.ca/adp Table of Amendments

More information

HEALTH PROFESSIONAL v SANOFI

HEALTH PROFESSIONAL v SANOFI CASE AUTH/3062/8/18 HEALTH PROFESSIONAL v SANOFI Toujeo leaflet A consultant physician complained about a six-page A5 gate-folded leavepiece produced by Sanofi. The leavepiece related to Toujeo (insulin

More information

EXENATIDE (BYETTA ) PROTOCOL, 5mcg and 10mcg SC injection pre-filled pens

EXENATIDE (BYETTA ) PROTOCOL, 5mcg and 10mcg SC injection pre-filled pens EXENATIDE (BYETTA ) PROTOCOL, 5mcg and 10mcg SC injection pre-filled pens This document should be read in conjunction with the current Summary of Product Characteristics http://www.medicines.org.uk 1.

More information

Consultation Group: Dr Amalia Mayo, Paediatric Consultant. Review Date: March Uncontrolled when printed. Version 2. Executive Sign-Off

Consultation Group: Dr Amalia Mayo, Paediatric Consultant. Review Date: March Uncontrolled when printed. Version 2. Executive Sign-Off Policy For The Adjustment Of Insulin Injections By Paediatric Diabetes Specialist Nurses/Community Paediatric Nurses Diabetes Working With Children Within NHS Grampian Co-ordinators: Lead Paediatric Diabetes

More information

New Clinical Solutions in Diabetes Care

New Clinical Solutions in Diabetes Care Welcome to the Lakeside Conference Centre and the New Clinical Solutions Conference 2011 A collaboration: Worldwide 346 million people have diabetes World Health Organisation In 2010 the estimated prevalence

More information

This Diabetes Policy should be read in conjunction with the Dealing with Medical Conditions Policy of Goulburn Region Preschool Association Inc.

This Diabetes Policy should be read in conjunction with the Dealing with Medical Conditions Policy of Goulburn Region Preschool Association Inc. DIABETES POLICY Mandatory Quality Area 2 The content of this policy was developed for KPV by advocacy and diabetes educators at Diabetes Australia Vic and the Royal Children s Hospital Melbourne s manager

More information

Pre-Dialysis Insulin Information for Patients with Type 2 Diabetes receiving haemodialysis

Pre-Dialysis Insulin Information for Patients with Type 2 Diabetes receiving haemodialysis Pre-Dialysis Insulin Information for Patients with Type 2 Diabetes receiving haemodialysis Exceptional healthcare, personally delivered 2 This leaflet is for patients with Type 2 diabetes who require insulin

More information

EFFECTIVE SHARE CARE AGREEMENT. FOR THE off license use of GLP1 mimetics in combination with insulin IN DUDLEY

EFFECTIVE SHARE CARE AGREEMENT. FOR THE off license use of GLP1 mimetics in combination with insulin IN DUDLEY Specialist details Patient identifier Name Tel: EFFECTIVE SHARE CARE AGREEMENT FOR THE off license use of GLP1 mimetics in combination with insulin IN DUDLEY The aim of Effective Shared Care Guidelines

More information

State of California Health and Human Services Agency Department of Health Care Services

State of California Health and Human Services Agency Department of Health Care Services State of California Health and Human Services Agency Department of Health Care Services JENNIFER KENT Director EDMOND G. BROWN JR Governor DATE: N.L.: 03-0317 Index: Benefits TO: ALL COUNTY CALIFORNIA

More information

National Paediatric Diabetes Audit

National Paediatric Diabetes Audit National Paediatric Diabetes Audit Parent and Carers Report 2015-16 Commissioned by the Healthcare Quality Improvement Partnership Managed by the Royal College of Paediatrics and Child Health National

More information

Mr Gavin Hendry. Mr Rab Burtun. Prof Jim Mann. Diabetes Nurse Facilitator, Auckland. Dunedin. Human Nutrition & Medicine University of Otago, Dunedin

Mr Gavin Hendry. Mr Rab Burtun. Prof Jim Mann. Diabetes Nurse Facilitator, Auckland. Dunedin. Human Nutrition & Medicine University of Otago, Dunedin Mr Rab Burtun Diabetes Nurse Facilitator, Auckland Mr Gavin Hendry Dunedin Prof Jim Mann Human Nutrition & Medicine University of Otago, Dunedin Insulin Master Class Presented by: Prof Jim Mann Gavin Hendry

More information

Dept of Diabetes Main Desk

Dept of Diabetes Main Desk Dept of Diabetes Main Desk 01202 448060 Glucose management in Type 2 Diabetes in Adults The natural history of type 2 diabetes is for HbA1c to deteriorate with time. A stepwise approach to treatment is

More information

Glucose Control drug treatments

Glucose Control drug treatments Glucose Control drug treatments It should be noted that glitazones are under suspicion of precipitating acute cardiac events and current recommendations contraindicate the use of glitazones in patients

More information

What the quality statement means for each audience

What the quality statement means for each audience Standard 19 Those with uncommon causes of diabetes (eg, cystic fibrosis, monogenic, postpancreatectomy) should have access to specialist expertise with experience in these conditions. Key practice points

More information